PDF电子书：LIPOPROTEINS – ROLE IN HEALTH AND DISEASES （2012）

xyklmu

/ M  T& B2 v- f& D% z. i7 r+ F, k& A9 k* B; _
[hide][/hide]
" G- ~$ G0 Z6 s, j( M6 ZLIPOPROTEINS – ROLE IN HEALTH AND DISEASES& q7 A6 h4 a6 P" \
Edited by Saša Frank and Gerhard Kostner
3 h0 f* o4 R1 C3 h5 h9 r" ^& P* A, H0 ~
共28章 774页4 Z. A  i4 H  |; w7 j; n8 g

8 y! J/ a. r+ p( h
* A( X. Q, l) _4 v% d1 p7 YContents; ~( ?4 \8 [: ]' I9 G! _8 Y
Preface XI8 }9 H  E. ]" \2 }1 a+ O
Section 1 Lipoprotein Structure and Assembly 1# D- }$ n# |% ^% P6 r" |& N
Chapter 1 Lipoprotein Structure and Dynamics: Low Density Lipoprotein Viewed as a Highly Dynamic and Flexible Nanoparticle 34 w$ c3 @) B! V
Ruth Prassl and Peter Laggner
1 P8 |* e) o3 ]# k8 ]  @Chapter 2 New Insights into the Assembly and Metabolism of ApoB-Containing Lipoproteins
) f) {9 d2 d9 L$ A) Mfrom in vivo Kinetic Studies: Results on Healthy Subjects and Patients with Chronic Kidney Disease 21+ R& {  r- J- P) ?) H, [7 v
Benjamin Dieplinger and Hans Dieplinger8 ]7 n' a& z/ \( Q
Section 2 Diagnosis of Lipoprotein Disorders 45# T# \- B: R! U$ z* t1 U1 H
Chapter 3 The Importance of Lipid and Lipoprote in Ratios in Interpretetions of Hyperlipidaemia of Pregnancy 47. Y0 Q, W+ k: d- g7 z7 F" v
D.S. Mshelia and A.A. Kullima
. o$ O. ~  y8 BChapter 4 A Non-Atherogenic and Atherogenic Lipoprotein Profile in Individuals with Dyslipoproteinemia 73
' @9 Y( Q; Y' EStanislav Oravec, Johannes Mikl,
2 t- q8 x( a2 R4 M& z% T- \/ |. _( aKristina Gruber and Elisabeth Dostal
- x1 @" ]3 U) p# i( |Chapter 5 The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk 95& Q5 S9 @1 |; Y* z
Göran Walldius% l" ?0 L: m& T/ v- |& q
Chapter 6 Approaches to Access Biological Data Sources 149
; d8 r4 }- k# ]7 `! p3 jAssia Rharbi, Khadija Amine, Zohra Bakkoury,
" M  L, ~2 \  P, e9 J* ]Afaf Mikou, Anass Kettani andAbdelkader Betari1 f* h5 Y7 H% h; F, u+ _
VI Contents
1 {; F/ H3 ~; B. r" i5 ^$ FSection 3 Hyper- and Dyslipoproteinemias 171: s2 Z- N4 z$ x$ X9 t
Chapter 7 Lipoproteins Impact Increasing Cardiovascular Mortality 173
6 y2 o- A8 `4 K1 ~Jelena Umbrasiene, Ruta-Marija Babarskiene and Jone Vencloviene
4 p9 y* l7 J& ]9 S) `- ZChapter 8 Lipoproteins and Cardiovascular Diseases 197
' k' k$ s: G3 B9 E+ JAdebowale Saba and Olayinka Oridupa
- `1 T6 \- y, V, Q2 _. QChapter 9 Linking the Pathobiology of Hypercholesterolemia with the Neutrophil Mechanotransduction 223) E# k' [* L7 Q: U: x  M5 {, G2 n
Xiaoyan Zhang and Hainsworth Y. Shin
. s  N# P# W! k9 N) ], SSection 4 Management of Hyper and Dyslipoproteinemias 253& o* l# Y! \- V3 ?% ~9 D
Chapter 10 The Confounding Factor of Apolipoprotein E on Response to Chemotherapy and Hormone Regulation Altering Long-Term Cognition Outcomes 255
7 L7 E5 w$ P8 D. u% ?8 uSummer F. Acevedo
# c" a2 l7 |) T# mChapter 11 Anticholesterolemic and Antiatherogenic Effects of Taurine Supplementation is Model Dependent 269
, B% U4 V  J) ?Karl-Erik Eilertsen, Rune Larsen, Hanne K. Mæhre, Ida-Johanne Jensen and Edel O. Elvevoll) V/ l8 z! Z+ B" D$ W8 @; u
Chapter 12 Endoscopic Treatment of Metabolic Syndrome 289
; d! [8 h# p  f. o; j. [& O7 @, [Eduardo Guimarães Hourneaux de Moura, Ivan Roberto Bonotto
1 Q9 Z$ M; I! t- l9 ?5 p7 P: o4 @6 oOrso, Bruno da Costa Martins and Guilherme Sauniti Lopes# r  X: d/ A& N$ F# F% ?. I6 O
Chapter 13 Nutritional Management of Disturbances in Lipoprotein Concentrations 303
3 C+ U: b$ Z& h' BSomayeh Hosseinpour-Niazi, Parvin Mirmiran and Fereidoun Azizi1 ?; @% G$ J2 S5 V2 K+ g
Chapter 14 Cyclosporin A-Induced Hyperlipidemia 337
3 \: {! O- z3 }  G) Z& R  mMaaike Kockx and Leonard Kritharides6 x( O7 T7 q" L+ Z
Chapter 15 Lipoproteins and Apolipoproteins of the Ageing Eye 3554 r$ B, k& M0 r; I+ {6 ^
Edward Loane
# i* x) |+ _" h% b/ c. E& G. vSection 5 Lipid Oxidation and Anti-Oxidants 381/ a6 N6 U) U( L& @
Chapter 16 Pathophysiology of Lipoprotein Oxidation 383
+ k4 l% h- n) aVikram Jairam, Koji Uchida and Vasanthy Narayanaswami: S0 X0 X" O7 K
Chapter 17 Oxidized Phospholipids: Introduction and Biological Significance 409- O3 ^3 _1 D% d
Mohammad Z. Ashraf and Swati Srivastava
3 m. @0 Y& q/ i# \. P8 @: {9 _Contents VII0 }2 B1 V% _: z1 V# u  [0 [
Chapter 18 HDL-Associated Paraoxonase 1 Gene Polymorphisms as a Genetic Markers for Wide Spread Diseases 4317 A; J# K: Z' z: ]8 Y# t
Ivana Pejin-Grubiša9 H1 M; m3 |8 W/ E
Chapter 19 Antioxidant Complexes and Lipoprotein Metabolism – Experience of Grape Extracts Application Under Metabolic Syndrome and Neurogenic Stress 445
. O- W% W( P$ AAndriy L. Zagayko, Anna B. Kravchenko,( B, C1 y4 v; e# t0 H
Mykhaylo V. Voloshchenko and Oxana A. Krasilnikova: V2 \' g( Q' ?( P8 X0 g
Chapter 20 The Anti-Atherogenic Effects of Lycopene 4896 o2 Q" F( ]- |8 ~* ?
Amany M. M. Basuny" J, Y% B# k0 O7 ~/ A5 v% M
Section 6 Animal Models for Lipoprotein Research 507
. y. l6 V" f% i, E7 _9 |Chapter 21 Animal Models as Tools for Translational Research: Focus on Atherosclerosis, Metabolic Syndrome and Type-II Diabetes Mellitus 509
1 m; l: p! g1 w4 HIsaac Karimi4 L- z! V( n- T, P/ e' N
Chapter 22 Genetically Modified Animal Models for Lipoprotein Research 533
- W' G7 C/ d) k1 u) iMasashi Shiomi, Tomonari Koike and Tatsuro Ishida$ w+ H" H: l% K. L* P; S# Z. y0 Q
Section 7 Role of Lipoproteins in Neurodegenerative Diseases 561
$ p" c. x. k* j5 j7 W, s. Q7 LChapter 23 Plasma Lipoproteins in Brain Inflammatory and Neurodegenerative Diseases 5632 U1 @- \+ D& I+ l6 r0 R" d: w  W% t
Armando Sena, Carlos Capela, Camila Nóbrega,
; |7 Q! ]2 K+ }( G. gVéronique Férret-Sena, Elisa Campos and Rui Pedrosa" B0 A2 z- E, s( ~$ \7 F
Chapter 24 Genetics of Ischemic Stroke: Emphasis on Candidate-Gene Association Studies 583# x/ v1 B) `" g1 l' i2 |
Sanja Stankovic, Milika Asanin and Nada Majkic-Singh' d5 b* t% P! K( c4 n
Chapter 25 Lipoproteins and Apolipoproteins in Alzheimer's Disease 613
9 n& N3 }" D2 m% F2 Q: g- nEtsuro Matsubara& ^5 L! t4 ], T' V. A0 S" W
Section 8 Lipoproteins and Cancer 621: R- Y% s/ b' _9 E: Z2 G' P6 V+ K
Chapter 26 Lipoproteins and Cancer 623+ B; H, _8 B0 K7 i5 \. `
Caryl J. Antalis and Kimberly K. Buhman
: t3 l/ N/ k  P1 vChapter 27 Role of Lipoproteins in Carcinogenesis and in Chemoprevention 647$ d3 i! p0 y0 b' c
Adebowale Bernard Saba and Temitayo Ajibade

s06806

我又回复了  

tuanzi

HOHO~~~~~~  

marysyq

好 好帖 很好帖 确实好帖 少见的好帖  

sky蓝

我等你哟!  

foxok

HOHO~~~~~~  

陈晴

我有家的感觉~~你知道吗  

我心飞翔

应该加分  

foxok

站个位在说  

aakkaa

支持~~